Literature DB >> 17938430

Helicobacter pylori and antibiotic resistance.

Francis Megraud1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17938430      PMCID： PMC2095668          DOI： 10.1136/gut.2007.132514

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  31 in total

1.  Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis.

Authors:  M Heep; U Rieger; D Beck; N Lehn
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 2.  Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE).

Authors:  L G Coelho; R León-Barúa; E M Quigley
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

3.  Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan.

Authors:  M Kato; Y Yamaoka; J J Kim; R Reddy; M Asaka; K Kashima; M S Osato; F A El-Zaatari; D Y Graham; D H Kwon
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

4.  Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy.

Authors:  M Heep; M Kist; S Strobel; D Beck; N Lehn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-07       Impact factor: 3.267

5.  Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999).

Authors:  J Cabrita; M Oleastro; R Matos; A Manhente; J Cabral; R Barros; A I Lopes; P Ramalho; B C Neves; A S Guerreiro
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

6.  Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study.

Authors:  F Mégraud; N Lehn; T Lind; E Bayerdörffer; C O'Morain; R Spiller; P Unge; S V van Zanten; M Wrangstadh; C F Burman
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

7.  Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.

Authors:  Y J Debets-Ossenkopp; A J Herscheid; R G Pot; E J Kuipers; J G Kusters; C M Vandenbroucke-Grauls
Journal:  J Antimicrob Chemother       Date:  1999-04       Impact factor: 5.790

Review 8.  Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group.

Authors:  R H Hunt; C A Fallone; A B Thomson
Journal:  Can J Gastroenterol       Date:  1999-04       Impact factor: 3.522

9.  Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.

Authors:  J J Kim; R Reddy; M Lee; J G Kim; F A El-Zaatari; M S Osato; D Y Graham; D H Kwon
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

10.  Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer.

Authors:  A Pilotto; M Rassu; G Leandro; M Franceschi; F Di Mario
Journal:  Dig Liver Dis       Date:  2000-12       Impact factor: 4.088
View more
  39 in total

1.  Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population.

Authors:  Luigi Gatta; Francesco Di Mario; Dino Vaira; Angelo Franzé; Massimo Rugge; Alberto Pilotto; Paolo Lucarini; Maurizio Lera; Giulia Fiorini; Valentina Castelli; Enkleda Kajo; Carmelo Scarpignato
Journal:  Intern Emerg Med       Date:  2010-08-19       Impact factor: 3.397

Review 2.  Meta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?

Authors:  Zhi-Fa Lv; Fu-Cai Wang; Hui-Lie Zheng; Ben Wang; Yong Xie; Xiao-Jiang Zhou; Nong-Hua Lv
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 3.  Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.

Authors:  Min-Min Zhang; Wei Qian; Ying-Yi Qin; Jia He; Yu-Hao Zhou
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

Review 4.  Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.

Authors:  Vasilios Papastergiou; Sotirios D Georgopoulos; Stylianos Karatapanis
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 5.  A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.

Authors:  Elvira Garza-González; Guillermo Ignacio Perez-Perez; Héctor Jesús Maldonado-Garza; Francisco Javier Bosques-Padilla
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Furazolidone, co-amoxiclav, colloidal bismuth subcitrate, and esomeprazole for patients who failed to eradicate Helicobacter pylori with triple therapy.

Authors:  Zaigham Abbas; Javed Yakoob; Shahab Abid; Wasim Jafri; Muhammad Islam; Zahid Azam; Imran Hilal
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

Review 7.  Eradication of Helicobacter pylori infection: which regimen first?

Authors:  Alessandro Federico; Antonietta Gerarda Gravina; Agnese Miranda; Carmela Loguercio; Marco Romano
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 8.  Probiotics for the treatment of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; John Frederick Osborn; Enea Bonci; Sara Romaggioli; Rossella Baldini; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 9.  Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.

Authors:  Simona Di Caro; Lucia Fini; Yayha Daoud; Fabio Grizzi; Antonio Gasbarrini; Antonino De Lorenzo; Laura Di Renzo; Sara McCartney; Stuart Bloom
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 10.  New concepts of resistance in the treatment of Helicobacter pylori infections.

Authors:  David Y Graham; Akiko Shiotani
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.